Fortis Malar Hospitals Ltd

BSE:FORTISMLR

HealthcareHealthcare Services

₹41.3

-1.03%1 Oct close

Mkt cap

₹77 Cr

Watch Alert Compare

About

Fortis Malar Hospitals Ltd operates in Hospital within the Healthcare sector.

Face value: ₹10

Market cap

₹77 Cr

P/E

18.7×

P/B

2.3×

Dividend yield

6.1%

ROE

12.8%

ROCE

14.6%

Debt / equity

OPM

—

EPS (TTM)

₹2.2

Book value

₹18.3

52-week high

—

52-week low

—

2,169 historical price candles were omitted because the exchange source has not been verified.

₹41.3-1.4%1Y

Quick read

rule-based

Pros

+Strong return on equity of 21.9% (3-yr avg)
+Almost debt-free (debt/equity 0)
+Dividend yield of 6.1%
+High promoter holding of 62.7% with no pledge

Cons

−Revenue shrank over the last 5 years (-76.5% a year)

Research score

Structured signal from quality, growth, valuation and momentum.

45/100

Business quality: 54
Growth: 0
Valuation

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	69	86	86	59	0	0
COGS	14	17	13	9	0	0
Gross profit	55	69	73	50	—	—
	62	66	69	51	2	2
	-6	3	5	-1	-2	-2
OPM %	-9.2%	4%	5.3%	-2.1%	—	—
Depreciation	13	13	12	9	0	0
Interest	7	7	6	4	0	0
	15	7	7	65	3	6
Profit before tax	-11	-8	-7	50	1	5
Tax	-3	0	8	5	0	1
Tax %	-30.4%	0.1%	120.8%	9.4%	31.6%	12.5%
	-8	-8	-15	45	0	4
PAT margin %	-11.4%	-9.6%	-18%	76.8%	—	—
EPS (₹)	—	—	—	24.2	0.2	2.2
EPS adjusted (₹)	-4.2	-4.4	-8.3	24.2	0.2	2.2
	—	—	—	10.3%	19,047.6%	—
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	19	19	19	19	19	19	19
Reserves	78	70	61	45	91	11	16
	—	0	53	46	0	0	0
	97	80	27	27	6	7	3
Total equity & liabilities	194	169	161	138	116	37	38
	21	69	58	47	0	0	0
CWIP	0	0	0	0	0	0	0
Investments	—	0	0	0	0	0	0
	173	100	103	91	116	37	38
Total assets	194	169	161	138	116	37	38

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	79.7%	80.3%	85.3%	85.1%	—	—
EBITDA margin %	-9.2%	4%	5.3%	-2.1%	—	-3,160%
EBIT margin %	-27.8%	-10.5%	-8.8%	-17.9%	—	-3,160%
PAT margin %	-11.4%	-9.6%	-18%	76.8%	—	8,280%
Working capital
Receivable days	11	9	14	0	—	0
Inventory days	42	40	32	0	—	0
Payable days	373	429	584	216	—	87
NWC days	-320	-380	-539	-216	—	-87
Leverage
Current ratio	2.43	1.56	2.66	17.67	5.15	11.32
Debt to EBITDA	—	15.53	10.15	—	—	—
Debt to equity	0	0.67	0.72	0	0	0
Interest coverage	-1.5	-0.3	-0.2	-0.8	58	—
Asset turnover	0.41	0.54	0.62	0.51	0	0
Return ratios
Return on assets %	-4.7%	-5.1%	-11.2%	39.1%	1.1%	11%
Return on capital employed %	-7.6%	-1.2%	-0.8%	-3.4%	0.8%	14.6%
Return on equity %	-8.9%	-10.3%	-24.1%	41.4%	1.3%	12.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	62.71%	62.71%	62.71%	14.4%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	0.07%	0.07%	0.07%	0.17%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	37.22%	37.22%	37.22%	85.43%	37.22%	37.22%	37.22%	37.22%	37.22%	37.22%	37.22%	37.22%
No. of shareholders	—	—	—	—	—	—	—	—	27,644	27,022	26,259	25,734

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Fortis Malar Hospitals Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

4

Final dividend24 Jul 2024 · ex-date₹2.5
Interim dividend23 Apr 2024 · ex-date₹40
Dividend dividend14 Sept 2015 · ex-date₹0.5
Interim dividend19 Sept 2013 · ex-date₹0.5

1

Board meeting to consider results4 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

0 announcementsExport CSV

No announcements stored for this window

Filings are ingested from BSE daily. Try a longer range, or check back after the next sync.

Loading announcements…

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	79.7%	80.3%	85.3%	85.1%	—	—
EBITDA margin %	-9.2%	4%	5.3%	-2.1%	—	-3,160%
EBIT margin %	-27.8%	-10.5%	-8.8%	-17.9%	—	-3,160%
PAT margin %	-11.4%	-9.6%	-18%	76.8%	—	8,280%
Working capital
Receivable days	11	9	14	0	—	0
Inventory days	42	40	32	0	—	0
Payable days	373	429	584	216	—	87
NWC days	-320	-380	-539	-216	—	-87
Leverage
Current ratio	2.43	1.56	2.66	17.67	5.15	11.32
Debt to EBITDA	—	15.53	10.15	—	—	—
Debt to equity	0	0.67	0.72	0	0	0
Interest coverage	-1.5	-0.3	-0.2	-0.8	58	—
Asset turnover	0.41	0.54	0.62	0.51	0	0
Return ratios
Return on assets %	-4.7%	-5.1%	-11.2%	39.1%	1.1%	11%
Return on capital employed %	-7.6%	-1.2%	-0.8%	-3.4%	0.8%	14.6%
Return on equity %	-8.9%	-10.3%	-24.1%	41.4%	1.3%	12.1%

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

4

Final dividend24 Jul 2024 · ex-date₹2.5
Interim dividend23 Apr 2024 · ex-date₹40
Dividend dividend14 Sept 2015 · ex-date₹0.5
Interim dividend19 Sept 2013 · ex-date₹0.5

1

Board meeting to consider results4 Aug 2026

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Fortis Malar Hospitals Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	62.71%	62.71%	62.71%	14.4%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%	62.71%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	0.07%	0.07%	0.07%	0.17%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	37.22%	37.22%	37.22%	85.43%	37.22%	37.22%	37.22%	37.22%	37.22%	37.22%	37.22%	37.22%
No. of shareholders	—	—	—	—	—	—	—	—	27,644	27,022	26,259	25,734

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

28 Jul 2026 · Board Meeting

Documents link to external sources (exchange filings, company investor pages).

Promoter holding up 0 percentage points since Sep 2023.

21 deals · 6 Feb 2024 – 14 Jun 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
14 Jun 2024	SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	BSE	Sell	1,00,000	₹70.93	₹0.71 Cr
10 Jun 2024	SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	BSE	Sell	96,495	₹58.80	₹0.57 Cr
10 Jun 2024	SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	BSE	Buy	555	₹58.16	₹0.00 Cr
6 Jun 2024	SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	BSE	Buy	1,50,356	₹56.42	₹0.85 Cr
6 Jun 2024	SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	BSE	Sell	89,544	₹56.13	₹0.50 Cr
27 May 2024	SAHASTRAA ADVISORS PRIVATE LIMITED	Bulk	BSE	Buy	1,00,000	₹65.93	₹0.66 Cr
23 Apr 2024	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	BSE	Sell	2,39,000	₹70.11	₹1.68 Cr
23 Apr 2024	CAMELLIA TRADEX PRIVATE LIMITED	Bulk	BSE	Sell	1,00,000	₹67.40	₹0.67 Cr
22 Apr 2024	MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED	Bulk	BSE	Buy	2,46,122	₹107.94	₹2.66 Cr
22 Apr 2024	CAMELLIA TRADEX PRIVATE LIMITED	Bulk	BSE	Buy	1,00,000	₹107.94	₹1.08 Cr

1–10 of 21

1 / 3

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. Daljit SinghNon-Executive - Non Independent Director-Chairperson
Ms. Ritu GargNon-Executive - Non Independent Director
Ms. Shailaja ChandraNon-Executive - Independent Director
Ms. Suvalaxmi ChakrabortyNon-Executive - Independent Director
Ms. Richa Singh DebguptaNon-Executive - Non Independent Director
Mr. Bidesh Chandra PaulExecutive Director
Mr. Pradeep Kumar MalhotraChief Financial Officer
Ms. Vinti VermaCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

1 month 3 months 6 months 1 year All

0 announcementsExport CSV

No announcements stored for this window

Filings are ingested from BSE daily. Try a longer range, or check back after the next sync.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	69	86	86	59	0	0
COGS	14	17	13	9	0	0
Gross profit	55	69	73	50	—	—
	62	66	69	51	2	2
	-6	3	5	-1	-2	-2
OPM %	-9.2%	4%	5.3%	-2.1%	—	—
Depreciation	13	13	12	9	0	0
Interest	7	7	6	4	0	0
	15	7	7	65	3	6
Profit before tax	-11	-8	-7	50	1	5
Tax	-3	0	8	5	0	1
Tax %	-30.4%	0.1%	120.8%	9.4%	31.6%	12.5%
	-8	-8	-15	45	0	4
PAT margin %	-11.4%	-9.6%	-18%	76.8%	—	—
EPS (₹)	—	—	—	24.2	0.2	2.2
EPS adjusted (₹)	-4.2	-4.4	-8.3	24.2	0.2	2.2
	—	—	—	10.3%	19,047.6%	—
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	19	19	19	19	19	19	19
Reserves	78	70	61	45	91	11	16
	—	0	53	46	0	0	0
	97	80	27	27	6	7	3
Total equity & liabilities	194	169	161	138	116	37	38
	21	69	58	47	0	0	0
CWIP	0	0	0	0	0	0	0
Investments	—	0	0	0	0	0	0
	173	100	103	91	116	37	38
Total assets	194	169	161	138	116	37	38

₹ Cr	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-16	-0	-1	7	6	-7	2	1
	6	50	-28	8	1	120	-29	0
	0	-12	-7	-10	-13	-11	-80	0
Net cash flow	-9	38	-36	5	-7	102	-107	1
Free cash flow	—	-4	-1	5	4	-10	2	1
CFO / Operating profit %	—	—	—	198.8%	122.8%	—	—	—

Compounded sales growth

7 years: —
5 years: -77%
3 years: -92%
1 year: —

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: 962%

Return on equity

7 years: —
5 years: 4%
3 years: 18%
Last year: 12%

Fortis Malar Hospitals Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Dividends4

Board meetings1

Announcements

No announcements stored for this window

Ratio timeline

Not in the F&O segment

Dividends4

Board meetings1

No fund holdings on record

Announcements

Quarterly record

Annual reports

Bulk & block deals

Board and management

No announcements stored for this window

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

4

1

4

1